Notes for class i98 2021

The US Centers for Disease Control and Prevention and the US Food and Drug Administration lifted the
pause on the Johnson & Johnson Covid-19 vaccine on Friday. The agencies previously had decided to
pause administration of the vaccine due to cases of an extremely rare blood clotting disorder found in
six women between the ages of 18 and 49 who had gotten the shot.

The initial pause was intended to inform health care providers about this rare disorder and its
treatment, and to see if other cases would emerge.

Out of the nearly 8 million doses of the Johnson & Johnson vaccine administered, the CDC said it has
confirmed that there have been 15 cases total of thrombosis with thrombocytopenia syndrome, or
blood clots with low platelets.

After reviewing the benefits and risks of the vaccine, an independent committee to the CDC
recommended that the vaccine continue to be administered, but with additional information about the
very rare possibility of TTS.

What does this mean for women -- those who have been given the vaccine and those who haven't but
are considering it?

We asked CNN Medical Analyst Dr. Leana Wen, an emergency physician and visiting professor of health
policy and management at the George Washington University Milken Institute School of Public Health.
She's also the author of the forthcoming book "Lifelines: A Doctor's Journey in the Fight for Public
Health."